A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

NCT05303467 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme
Recurrent Glioblastoma

Interventions

DEVICE: TheraSphere GBM

Sponsor

Boston Scientific Corporation